68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?

2017 ◽  
Vol 169 (1-2) ◽  
pp. 3-11 ◽  
Author(s):  
Christian Uprimny
Keyword(s):  
Prostate Cancer ◽  
Nuclear Medicine ◽  
Cancer Imaging ◽  
Pet Ct

[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0

2019 ◽  
Vol 47 (3) ◽  
pp. 579-591 ◽  
Author(s):  
Cristina Nanni ◽  
Lucia Zanoni ◽  
Tore Bach-Gansmo ◽  
Heikki Minn ◽  
Frode Willoch ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Imaging ◽  
Pet Ct

scholarly journals UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging

2019 ◽  
Vol 40 (7) ◽  
pp. 662-674 ◽  
Author(s):  
Asim Afaq ◽  
Fergus Gleeson ◽  
Andrew Scarsbrook ◽  
Kevin Bradley ◽  
Manil Subesinghe ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Imaging ◽  
Pet Ct

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

2017 ◽  
Vol 44 (6) ◽  
pp. 1014-1024 ◽  
Author(s):  
Wolfgang P. Fendler ◽  
Matthias Eiber ◽  
Mohsen Beheshti ◽  
Jamshed Bomanji ◽  
Francesco Ceci ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Imaging ◽  
Psma Pet ◽  
Pet Ct

Theranostics of Metastatic Prostate Cancer Applying 64Cu/18F/68Ga PSMA PET-CT and 177Lu Radiopharmaceuticals

2020 ◽  
Vol 13 ◽  
Author(s):  
Siroos Mirzaei ◽  
Fairoz Mohammed ◽  
Shahin Zandieh
Keyword(s):  
Prostate Cancer ◽  
Nuclear Medicine ◽  
Radionuclide Therapy ◽  
Metastatic Prostate Cancer ◽  
Therapy Response ◽  
Radioligand Therapy ◽  
Psma Pet ◽  
Pet Ct ◽  
Diagnostic Sensitivity And Specificity ◽  
Tumor Types

: The successful use of theranostic twins in neuroendocrine tumors (NET) was the pioneering approach to radionuclide therapy in other tumor types. 64Cu/18F PSMA for molecular imaging with PET-CT and peptide radioligand therapy (PRLT) with 177Lu labeled PSMA inhibitors are the next theranostic twins in nuclear medicine. 68Ga/ 64Cu/18F PSMA PET-CT detects metastatic prostate cancer with high diagnostic sensitivity and specificity and can be used to select patients for PRLT and evaluate therapy response. Radionuclide therapy with 177Lu-PSMA inhibitors has been shown to be effective in the treatment of metastatic CRPC.

HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer

2019 ◽  
Vol 7 (1) ◽  
pp. 7-20 ◽  
Author(s):  
Lorena Pozzo ◽  
Lucilena Rebelo Monteiro ◽  
Juliano Julio Cerci ◽  
Stefano Fanti ◽  
Antonella Negro ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Nuclear Medicine ◽  
Psma Pet ◽  
Pet Ct

scholarly journals Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Alejandro Sanchez-Crespo ◽  
Emma Jussing ◽  
Ann-Charlotte Björklund ◽  
Katja Pokrovskaja Tamm
Keyword(s):  
Prostate Cancer ◽  
Cancer Imaging ◽  
Detection Limits ◽  
Pet Ct ◽  
Quantitative Properties

Feasibility of Intraprostatic Prostate Cancer Imaging with FCH-PET/CT for Preoperative Planning of Image-Guided HDR Brachytherapy

Brachytherapy ◽  
2019 ◽  
Vol 18 (3) ◽  
pp. S72
Author(s):  
Eric Vigneault ◽  
Damien Carignan ◽  
Frédéric Pouliot ◽  
André-Guy Martin ◽  
William Foster ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Preoperative Planning ◽  
Cancer Imaging ◽  
Hdr Brachytherapy ◽  
Image Guided ◽  
Pet Ct
Sign in / Sign up

Export Citation Format

Share Document